Get started

Stockstrading

Reduction in Heart Attacks, Strokes and Cardiac DeathSingle Dose of Rexlemestrocel-L Provides Substantial and Durable Reduction in Heart Attacks, Strokes and Cardiac Death in Patients With Chronic Heart Failure results from the landmark DREAM-HF randomized controlled Phase 3 trial in 537 treated patients with chronic heart failure with reduced left ventricular ejection fraction (HFrEF) who received rexlemestrocel-L (REVASCOR®) or control sham. A single dose of rexlemestrocel-L resulted in substantial and durable reductions in heart attacks, strokes, and cardiac deaths. The incidence of heart attacks and strokes were reduced by 60% over a median follow-up period of 30 months following a single dose of rexlemestrocel-L in the population of 537 patients with New York Heart Association (NYHA) class II or III chronic heart failure (5% vs 13%, p=0.002). The incidence of death from cardiovascular causes was reduced by 60% following a single dose of rexlemestrocel-L in the 206 patients with NYHA class II disease (8% vs 20%, p=0.037) finance.yahoo.com
NASDAQ:MESO
by AlenCiken
1
LM Funding Announces Filing of SPAC Registration StatementLM Funding Announces Filing of SPAC Registration Statement LMFA today announced that LMF Acquisition Opportunities, Inc., a special purpose acquisition company and an indirect subsidiary of the Company ("LMF Acquisition"), filed a Registration Statement on Form S-1 (the "Registration Statement") with the Securities and Exchange Commission ("SEC") in connection with a proposed initial public offering of its units. LMF Acquisition intends to search for a target in the financial services industry, including potentially the financial technology (FinTech) sector, and related sectors. The proposed public offering is expected to have a base offering size of $75 million, or up to $86.25 million if the underwriters' over-allotment option is exercised in full. finance.yahoo.com
NASDAQ:LMFA
by AlenCiken
5
TTD: Buying opportunity with the trend"Trend is your friend" as they say and for me it's a personal guiding though implemented in my technical analysis. TTD's correction has ended and currently we have a affirmative bounce from the internal fractal support line. RSI and MACD's histogram are signaling for a reversal, though MACD hasn't made it's crossing yet. Thursday's close was with a pinbar and Friday we saw some goo buying action supported by above average daily volume of activity. In worst case scenario if bulls loose control we may see a further drop towards the $633 - $600 zone.
NASDAQ:TTDLong
by DailyChartist
Why Qudian Stock Popped higher in 2021?Why Qudian Stock Popped higher in 2021? On Dec 30, 2020 in Brussels, European Union negotiators finalized the terms of a historic investment agreement with China. Seven years in the making, the new Comprehensive Agreement on Investment is expected to grow international trade between the EU and China, facilitate cross-border investment, and "strongly stimulate" the economies of both nations, according to Chinese president Xi Jinping. CNN highlighted the financial services sector, electric vehicles, and healthcare as three areas of the Chinese economy likely to benefit especially from the trade accord. Don't expect to see immediate benefits for Qudian Stock, however. Just because negotiators have signed the deal doesn't mean that their respective legislatures will ratify it, and the Comprehensive Agreement can't go into effect before that happens. According to FT, EU officials are targeting an effective date for the agreement no earlier than 2022. www.fool.com
NYSE:QD
by AlenCiken
GSAT Announces Nokia Deployment Over Licensed Band 53 at SeattleGlobalstar Announces Nokia Deployment Over Licensed Band 53 at Port of Seattle Globalstar today announced that business partner Nokia has entered into an agreement with Tideworks Technology, to deploy Globalstar’s Band 53 spectrum at the Port of Seattle, Terminal 5. This deployment marks the second collaboration between Globalstar and Nokia at a United States Port. Band 53 offers partners secure and reliable connectivity in any environment. Utilizing the band allows customers to deploy considerably less access points than when relying on Wi-Fi leading to superior security, performance and long-term value." Globalstar has worked to develop the Band 53 ecosystem with a group of priority partners like Nokia. Globalstar’s Band 53 is a prime mid-band spectrum resource that we offer to our partners for deployment with customers that otherwise would not have access to the benefits of licensed spectrum. The combination of Nokia’s global reach and Globalstar’s Band 53 terrestrial authorizations in multiple countries around the globe present an exciting opportunity for secure wireless solutions. finance.yahoo.com
AMEX:GSAT
by AlenCiken
Bakkt Expected to Go Public via Reverse-Merger with VPCBakkt Expected to Go Public via Reverse-Merger with VPC Impact Acquisition Holdings In a move which is expected to be announced in the coming days/weeks, digital asset service provider ‘Bakkt’ is said to be finalizing a merger with VPC Impact Acquisition Holdings (VPC). The move, first reported by Bloomberg, is believed to be in its final stages. If completed it would be what is known as a ‘reverse merger’. For a company such as Bakkt, which has already raised hundreds of millions from existing investors, why is such a merger necessary? Simply put – it is often a cheaper and quicker way for a company to go public, as opposed to hosting its own IPO. These benefits are the sole reason VPC Impact Acquisition Holdings hosted its own IPO months ago. The company was created with the purpose and intent to go public, and subsequently be acquired by a promising company, such as Bakkt. At the time of its IPO, the company stated, Bloomberg notes in its report that insiders with knowledge on the matter believe that post-merger, the companies will see a valuation of roughly $2 billion USD. Dating back to mid-2018, Bakkt, was one of the most anticipated platforms geared to enter blockchain industry. While the company has come a long way since – becoming a popular service provider for BTC futures – it has experienced various hiccups along the way. Not only have multiple of the platforms expected services been delayed, but it has lost multiple CEO’s since its founding. Hopefully, between the increasing popularity of the digital asset industry itself, increasing volumes of its custodial and futures services, and upcoming loyalty spending program, these struggles are a thing of the past for Bakkt.
V
by AlenCiken
ALDX Announces Positive Top-Line Symptom and Sign ResultsAldeyra Therapeutics Announces Positive Top-Line Symptom and Sign Results from Run-In Cohort of Phase 3 TRANQUILITY Trial in Dry Eye Disease Statistical Significance of Reproxalap Over Vehicle Achieved for Ocular Redness, an FDA-Approvable Sign, and Clinical Symptoms of Ocular Dryness and Discomfort Acute Improvement in Ocular Redness and Symptom Scores Demonstrated Within Minutes of Reproxalap Administration in Dry Eye Chamber Main Cohort of TRANQUILITY Expected to Begin Enrollment in February 2021, Following Completion of Tear RASP Analysis and Finalization of Trial Design finance.yahoo.com
NASDAQ:ALDX
by AlenCiken
Why CNET 3D-Printing Stock Soared YesterdayShares of 3D-printing companies rose sharply on Thursday after 3D Systems (NYSE:DDD) reported blockbuster preliminary results for the fourth quarter. This news has given investors hope that other companies in the sector will report similarly strong results. in the first three quarters of 2020, Stratasys's total revenue fell by more than 20% year over year. The strong preliminary results from 3D Systems are sparking investor optimism that the 3D-printing industry is about to come roaring back as manufacturing activity picks up and economies start to recover from the havoc caused by the pandemic. www.fool.com
NASDAQ:SSYS
by AlenCiken
SOS to Expand into Digital Assets Security IndustryDr. Huazhong (Eric) Yan A Renowned Cryptocurrencies Security Expert Joins SOS to Spearhead SOSs Effort to Expand into Digital Assets Security Industry Dr. Yan is expected to utilize his cryptocurrency mining, protection, insurance expertise and his industry resources to lead SOS's efforts to set up a new business to apply blockchain-based security and insurance technologies in the safeguard of cryptocurrencies and digital assets, and strategically upgrade SOS's existing portfolios of products and services. SOS plans to set up a new wholly owned subsidiary SOS Digital Technologies Inc., to be led by Dr Yan. SOS anticipates to utilize the new subsidiary to be spearheaded by Dr. Yan to provide the infrastructure services in blockchain security for its big data insurance marketing and rescue services, and even providing insurance and banking services for digital assets and cryptocurrencies. Dr Yan has applied seven patents in China related to decentralized cryptocurrency wallets and exchanges, the protections and insurance for digital assets and cryptocurrencies, and blockchain-based security framework and solutions. The truly decentralized cryptocurrency wallet and exchange technologies developed by Dr Yan have been proven to be bullet-proof. Once SOS Digital Technologies Inc is created, SOS plans to launch the first digital assets insurance company and the first cryptocurrency bank in the world, backed up by Dr Yan's technologies. This venture is urgent as about 20% of cryptocurrencies are stolen or lost every year. Such venture is highly necessary as DCEP, the sovereign cryptocurrency offered by the central Bank of China, is in its testing stage and other sovereign cryptocurrencies are coming soon." finance.yahoo.com
NYSE:SOS
by AlenCiken
3
COCA-COLA ON THE S/R ZONE🙋‍♂️ Hello Stocks Community! Coca Cola is now on the key S/R zone of 2021. You can see my prepared trade with SL and TP! More information about my trading style: I am not a pattern trader. My strategy and edge are based on volume zones where I see Big players were trading. When the market comes there, I want to enter a trade. Every day I identify key levels and key zones, then I just wait for the price to come. Hope it helps, See you next time!
NYSE:KOLong
by Asanato
2
The revival of Energy - XLE on the riseXLE has been in a range for quite some time with the fall of Oil price from the first lockdown. But as thing recover and demand for Oil is returning to somewhat normal levels, the ETF is starting to give signs of life as well. RSI well above 50 and is moving slowly into overbought territory, but this means that there is more room for the price to rise. MACD has made a crossover and the histogram is turning positive. Resistance level circa 40 has been breached.
AMEX:XLELong
by DailyChartist
ISR has received FDA 510(k) clearanceC4 Imaging Announces Sirius Positive Signal MRI Marker Given FDA 510(k) Clearance for Use with Isoray’s Cesium-131 Brachytherapy Seeds to Treat Prostate Cancer ISR has received FDA 510(k) clearance for the use of C4 Imaging’s Sirius® positive-signal MRI (Magnetic Resonance Imaging) Markers with Isoray’s Cesium-131, brachytherapy seeds. Sirius MRI Markers will enable Isoray’s customers to fully utilize the benefits of MRI seed localization. Brachytherapy, or internal radiation therapy, is a leading, cost-effective option for the treatment of prostate cancer. Isoray is the world’s only producer of Cesium-131, commercially known as Cesium Blu™, brachytherapy seeds. Cesium-131 is a radioactive isotope that delivers a minimally invasive and highly targeted treatment to the site of the cancer preserving healthy tissue and organs. Patients benefit from the rapid resolution of their side effects allowing them to return to their normal lives quickly. finance.yahoo.com
I
by AlenCiken
2
“Strong Buy” Penny Stock That Could Deliver Massive Returns“Strong Buy” Penny Stock That Could Deliver Massive Returns The company’s development pipeline features drug candidates under investigation as treatments for short bowel syndrome (SBS) and celiac disease (CeD), two conditions that are both dangerous and difficult to treat. 9 Meters’ flagship product, Larazotide, is in Phase 3 development for the treatment of CeD. CeD affects about 1% of the population, yet there are no approved therapies. Top-line data from the study is expected in the second half of 2021. this past December, the company announced that it had entered an agreement with EBRIS, the European Biomedical Research Institute of Salerno, to investigate Larazotide as a potential treatment for respiratory complications due to COVID-19. The other major drug in the company’s pipeline is NM-002, for SBS. The company has recently announced positive Phase 1b/2a results, with a measurable impact on disease symptoms from a compound that was well-tolerated by patients. finance.yahoo.com
N
by AlenCiken
The9 to Start the Cryptocurrencies BusinessThe9 Signed a Legally Binding Cooperation and Investment Term Sheet with Cryptocurrencies Mining Investors Led by Jianping Kong to Start the Cryptocurrencies Business The9 has begun to deploy its blockchain and cryptocurrencies business strategy. This time, we are cooperating with investors including Mr. Jianping Kong. They have rich experience and resources in the field of cryptocurrencies mining machine manufacturing and cryptocurrencies mining operation and should be able to assist The9 to launch our cryptocurrencies mining operation. Our goal is to build up cryptocurrencies mining machines for The9 that will contribute 8% to 10% of the global hash rate of Bitcoin, 10% of the global hash rate of Ethereum and 10% of the global hash rate of Grin and become one of the world's largest cryptocurrencies mining companies in terms of hash rate. This will also speed up our other cryptocurrency related businesses. It has been 12 years since the birth of Bitcoin. Pursuant to the Term Sheet, The9 will issue Class A ordinary shares and warrants to the Investors. The9 is expected to receive proceeds from the transactions contemplated under the Term Sheet in accordance with certain pre-agreed conditions, if realized. The Investors are expected to utilize their cryptocurrencies mining industry resources to assist The9 for its development of cryptocurrencies mining business. The9 will set up a new wholly owned subsidiary NBTC Limited to operate its blockchain and cryptocurrencies business. The9 will issue 8,108,100 Class A ordinary shares (equivalent to 270,270 ADSs) at US$0.1233 per Class A ordinary share (equivalent to US$3.7 per ADS) and 207,891,900 warrants, each warrant representing the right to purchase one Class A Ordinary share (equivalent to 6,929,730 ADSs assuming full exercise of warrants) to the Investors. The warrants will be divided into four equal tranches: - The exercise price of three tranches of warrants is US$0.1233 per Class A ordinary share (equivalent to US$3.7 per ADS) - The exercise price of the other tranche of warrants is US$0.2667 per Class A ordinary share (equivalent to US$8 per ADS). Each tranche of the warrants is subject to its vesting conditions including market capitalization of The9 reaching US$100 million, US$300 million, US$500 million and US$1 billion within the timeframes of 6 months, 12 months, 24 months and 36 months, respectively. If the Investors exercise all of the warrants, The9 is expected to raise an aggregate consideration of approximately US$34 million in this transaction from the Class A ordinary shares issuance consideration and warrants exercise. The9 has the right to decide whether the Investors shall make payments in the form of U.S. dollars or cryptocurrencies (including Bitcoin) in the definitive agreement. finance.yahoo.com
NASDAQ:NCTYLong
by AlenCiken